TY - JOUR
T1 - Telemedicine-Based Treatment Versus Hospitalization in Patients with Severe Chronic Obstructive Pulmonary Disease and Exacerbation: Effect on Cognitive Function. A Randomized Clinical Trial
AU - Schou, Lone
AU - Østergaard , Birte
AU - Rasmussen, Lars S
AU - Rydahl-Hansen, Susan
AU - Jakobsen, Anna S
AU - Emme, Christina
AU - Phanareth, Klaus
PY - 2014/7
Y1 - 2014/7
N2 - Objectives: Telemedicine is gaining ground in the treatment of patients with chronic obstructive pulmonary disease (COPD). Because telemedicine often requires both participation and engagement of the patients, it is important to take differences in cognitive ability into account, as there is evidence that cognitive dysfunction may be a limitation in patients with severe COPD. The aim of this study was to investigate whether cognitive performance is better after telemedicine-based treatment than after conventional hospitalization in patients with severe COPD and a mild to moderate exacerbation. Materials and Methods: This randomized study was a substudy of the "Virtual Hospital," a multicenter, randomized controlled trial. The primary outcome in this substudy was cognitive function, evaluated 3 days and 6 weeks after discharge using a neuropsychological test battery comprising four tests and seven variables. Results: We included 44 patients consecutively. Baseline characteristics were as follows: mean age, 70 (standard deviation [SD] 10) years; mean forced expiratory volume in 1 s, 1.0 (SD 0.55) L (42% of predicted); mean hemoglobin oxygen saturation, 95 (SD 2.0) percent; and mean Mini Mental State Examination score, 27.5 (SD 1.6) points. The performance in all seven neuropsychological test variables tended to be better in the group allocated to virtual admission 3 days and 6 weeks after discharge, but the difference was not significant after Bonferroni's correction for multiple comparisons. Conclusions: There were no significant differences in cognitive performance between the telemedicine-based group and the conventional hospital group. Patients with severe COPD suffering from mild to moderate exacerbations were able to manage the telemedicine-based treatment despite the reduced cognitive function often seen in COPD patients.
AB - Objectives: Telemedicine is gaining ground in the treatment of patients with chronic obstructive pulmonary disease (COPD). Because telemedicine often requires both participation and engagement of the patients, it is important to take differences in cognitive ability into account, as there is evidence that cognitive dysfunction may be a limitation in patients with severe COPD. The aim of this study was to investigate whether cognitive performance is better after telemedicine-based treatment than after conventional hospitalization in patients with severe COPD and a mild to moderate exacerbation. Materials and Methods: This randomized study was a substudy of the "Virtual Hospital," a multicenter, randomized controlled trial. The primary outcome in this substudy was cognitive function, evaluated 3 days and 6 weeks after discharge using a neuropsychological test battery comprising four tests and seven variables. Results: We included 44 patients consecutively. Baseline characteristics were as follows: mean age, 70 (standard deviation [SD] 10) years; mean forced expiratory volume in 1 s, 1.0 (SD 0.55) L (42% of predicted); mean hemoglobin oxygen saturation, 95 (SD 2.0) percent; and mean Mini Mental State Examination score, 27.5 (SD 1.6) points. The performance in all seven neuropsychological test variables tended to be better in the group allocated to virtual admission 3 days and 6 weeks after discharge, but the difference was not significant after Bonferroni's correction for multiple comparisons. Conclusions: There were no significant differences in cognitive performance between the telemedicine-based group and the conventional hospital group. Patients with severe COPD suffering from mild to moderate exacerbations were able to manage the telemedicine-based treatment despite the reduced cognitive function often seen in COPD patients.
KW - chronic obstructive pulmonary disease
KW - cognitive function
KW - cognitive performance
KW - neuropsychological testing
KW - randomized clinical trial
KW - telemedicine
KW - User-Computer Interface
KW - Follow-Up Studies
KW - Humans
KW - Middle Aged
KW - Male
KW - Time Factors
KW - Female
KW - Hospitalization/statistics & numerical data
KW - Severity of Illness Index
KW - Risk Assessment
KW - Forced Expiratory Volume/physiology
KW - Hospitals, University
KW - Survival Rate
KW - Treatment Outcome
KW - Disease Progression
KW - Telemedicine/methods
KW - Neuropsychological Tests
KW - Pulmonary Disease, Chronic Obstructive/diagnosis
KW - Denmark
KW - Aged
KW - Cognition/physiology
U2 - 10.1089/tmj.2013.0224
DO - 10.1089/tmj.2013.0224
M3 - Journal article
C2 - 24820535
SN - 1530-5627
VL - 20
SP - 640
EP - 646
JO - Telemedicine and e-Health
JF - Telemedicine and e-Health
IS - 7
ER -